We are live on ! Find out more
GMAB icon

Genmab
GMAB

193 hedge funds and large institutions have $1.43B invested in Genmab in 2022 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 79 increasing their positions, 60 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

71% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 21

32% more repeat investments, than reductions

Existing positions increased: 79 | Existing positions reduced: 60

24% more capital invested

Capital invested by funds: $1.15B → $1.43B (+$276M)

13.43% more ownership

Funds ownership: 54.07% → 67.5% (+13%)

7% more funds holding

Funds holding: 180 → 193 (+13)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
193
Holders Change
+13
Holders Change %
+7.22%
% of All Funds
3.32%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
36
Increased
79
Reduced
60
Closed
21
Calls
$7.94M
Puts
–
Net Calls
+$7.94M
Net Calls Change
+$3.56M

Top Buyers

Rank Fund Capital Flow
1
AllianceBernstein
AllianceBernstein
Tennessee
+$203M
2
First Trust Advisors
First Trust Advisors
Illinois
+$45.3M
3
1832 Asset Management
1832 Asset Management
Ontario, Canada
+$33.4M
4
CCM
CAAS Capital Management
New York
+$12.3M
5
Goldman Sachs
Goldman Sachs
New York
+$8.03M

Top Sellers

Rank Fund Capital Flow
1
Artisan Partners
Artisan Partners
Wisconsin
-$15M
2
Macquarie Group
Macquarie Group
Australia
-$9.87M
3
BlackRock
BlackRock
New York
-$6.14M
4
CFM
Capricorn Fund Managers
United Kingdom
-$4.8M
5
HJGA
Hardman Johnston Global Advisors
Connecticut
-$3.12M
Name Holding Trade Value Shares
Change 		Change in
Stake
NW
76
NewEdge Wealth
Pennsylvania
$976K +$151K +4,305 +17%
BNP Paribas Asset Management
77
BNP Paribas Asset Management
France
$938K -$149K -4,232 -13%
CGPCS
78
Capital Group Private Client Services
California
$919K -$268K -7,624 -21%
RCMU
79
Rokos Capital Management (UK)
United Kingdom
$889K – – –
VWM
80
Venturi Wealth Management
Texas
$874K +$15.3K +436 +2%
SFI
81
Susquehanna Fundamental Investments
Pennsylvania
$863K +$943K +26,868 New
AssetMark Inc
82
AssetMark Inc
California
$815K +$210K +5,993 +31%
Comerica Bank
83
Comerica Bank
Texas
$800K +$140K +3,997 +23%
Osaic Holdings
84
Osaic Holdings
Arizona
$759K +$214K +6,106 +35%
VIA
85
Vident Investment Advisory
Georgia
$726K -$43.2K -1,231 -5%
MYIA
86
Mount Yale Investment Advisors
Colorado
$716K +$332K +9,461 +74%
BCI
87
Brinker Capital Investments
Pennsylvania
$708K +$4.49K +128 +0.6%
CS
88
Credit Suisse
Switzerland
$669K -$721K -20,540 -50%
LA
89
LVW Advisors
New York
$666K +$527 +15 +0.1%
Truist Financial
90
Truist Financial
North Carolina
$662K +$196K +5,568 +37%
CI
91
Clal Insurance
Israel
$643K -$1M -28,600 -59%
SS
92
Simplicity Solutions
Minnesota
$627K +$53K +1,510 +8%
Jane Street
93
Jane Street
New York
$604K +$653K +18,604 New
IIC
94
Integrated Investment Consultants
Michigan
$592K -$4.21K -120 -0.6%
Ensign Peak Advisors
95
Ensign Peak Advisors
Utah
$585K – – –
Mariner
96
Mariner
Kansas
$568K +$621K +17,689 New
MAM
97
Marotta Asset Management
Virginia
$555K +$2.56K +73 +0.4%
LNWWM
98
Laird Norton Wetherby Wealth Management
California
$525K +$149K +4,253 +35%
Prudential Financial
99
Prudential Financial
New Jersey
$524K +$576K +16,412 New
LWAM
100
Legacy Wealth Asset Management
Minnesota
$514K +$562K +16,013 New
2 3
4
5 6

GMAB Hedge Fund Activity: Q3 2022 in Review

193 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Genmab (GMAB) for Q3 2022, worth a combined $1.43B — up 24% from $1.15B a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new GMAB positions and 21 closed out — a net gain of 15 holders — while 79 added to existing stakes and 60 trimmed.

The largest buyer was AllianceBernstein, opening a new position worth an estimated $203M. The largest seller was Artisan Partners, cutting an estimated $15M.

  • 193 institutional investors held Genmab (GMAB) as of Q3 2022, up from 180 in Q2 2022.
  • Funds reported $1.43B of Genmab stock for Q3 2022, up 24% quarter-over-quarter.
  • 36 funds opened new Genmab positions in Q3 2022 and 21 closed out, a net change of +15 holders.
  • The largest Genmab buyer in Q3 2022 was AllianceBernstein, an estimated $203M added.
  • The largest Genmab seller in Q3 2022 was Artisan Partners, an estimated $15M sold.

Based on aggregated 13F filings for Q3 2022.